The general trend of the three HER2/neu-positive breast cancer cell lines tested was that they possessed higher basal levels of DDIT3/CHOP, ATF6 and spliced XBP1 and that these levels increased in response to palmitate treatment (Additional file 1: Figure S7). The gene discussed is ATF6; the disease is breast cancer.